Your browser doesn't support javascript.
loading
Detection of antibodies to denatured human leucocyte antigen molecules by single antigen Luminex.
Gutiérrez-Larrañaga, María; Riesco, Laura; Guiral, Sandra; Irure, Juan; Rodrigo, Emilio; Ocejo-Vinyals, Javier; Martorell, Jaume; Caro, Jose L; López-Hoyos, Marcos; San Segundo, David.
Afiliação
  • Gutiérrez-Larrañaga M; Immunology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
  • Riesco L; Tissue Typing Laboratory, University Hospital Marqués de Valdecilla, Santander, Spain.
  • Guiral S; Immunology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
  • Irure J; Tissue Typing Laboratory, University Hospital Marqués de Valdecilla, Santander, Spain.
  • Rodrigo E; Immunology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
  • Ocejo-Vinyals J; Tissue Typing Laboratory, University Hospital Marqués de Valdecilla, Santander, Spain.
  • Martorell J; Immunology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
  • Caro JL; Tissue Typing Laboratory, University Hospital Marqués de Valdecilla, Santander, Spain.
  • López-Hoyos M; Nephrology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
  • San Segundo D; Immunology Department, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
HLA ; 97(1): 52-59, 2021 01.
Article em En | MEDLINE | ID: mdl-33040479
ABSTRACT
The anti-HLA antibody detection has been improved in sensitivity and specificity with solid-phase antigen bead (SAB) assays based on Luminex. However, false positive results due to denatured HLA (dHLA) may arise after single antigen test. The aim of this study was to compare the performance of the two Luminex technology-based anti-HLA detection kits available in the market in showing undesired anti-HLA antibody results. A prospective cohort was assessed for anti-HLA antibodies with single antigen A manufacturer (AM) kit and a comparison cohort with single antigen B manufacturer (BM) kit. A total of 11 out of 90 patients in a prospective cohort presented monospecific HLA-I antibodies with AM, and 5 out of 11 confirmed monospecific reaction with BM. Despite the confirmation of monospecific reaction with both manufacturers, 80% were assigned as dHLA reaction by specific crossmatch. Further comparative cohorts detected four out of six monospecific reactions with BM that were confirmed as possible dHLA reactions. A positive SAB test should rule out a reaction against a dHLA molecule, thus avoidance of prolonged waitlist periods or misattribution of anti-HLA reactions after transplantation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos HLA / Isoanticorpos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Humans Idioma: En Revista: HLA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígenos HLA / Isoanticorpos Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Humans Idioma: En Revista: HLA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha